Search

Your search keyword '"Peristeri, Ioulia"' showing total 41 results
Start Over Author "Peristeri, Ioulia"
41 results on '"Peristeri, Ioulia"'

2. IMMUNOPHENOTYPE IN SAMD9/9L SYNDROME: CORRELATIONS WITH MORPHOLOGY

Author

Kelaidi, Charikleia, primary, Tzanoudaki, Marianna, additional, Petrikkos, Loizos, additional, Dana, Eleni, additional, Tourkantoni, Natalia, additional, Pelagiadis, Iordanis, additional, Antoniadi, Kondylia, additional, Ioannidou, Eleni-Dikaia, additional, Kourti, Maria, additional, Kosmidis, Helen, additional, Stiakaki, Eftychia, additional, Oikonomou, Marina, additional, Goussetis, Evgenios, additional, Peristeri, Ioulia, additional, Kattamis, Antonis, additional, Bountali, Aikaterini, additional, Manola, Kalliopi, additional, Stefanaki, Kalliopi, additional, and Polychronopoulou, Sophia, additional

Published
2023
Full Text
View/download PDF

3. A CASE OF KRAS-MUTATED JMML WITH HIGH METHYLATION PROFILE AND PERPLEXED CLINICAL COURSE.

Author

Tzotzola, Vasiliki, primary, Antoniadi, Kondylia, additional, Kelaidi, Charikleia, additional, Petrikkos, Loizos, additional, Ioannidou, Elda, additional, Goussetis, Evgenios, additional, Bountali, Aikaterini, additional, Manola, Kalliopi, additional, Mantadakis, Elpidoforos, additional, Stefanaki, Kalliopi, additional, Peristeri, Ioulia, additional, Niemeyer, Charlotte, additional, and Polychronopoulou, Sophia, additional

Published
2023
Full Text
View/download PDF

5. P23 - THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (t-MDS) IN CHILDHOOD: THE EXPERIENCE OF THE HELLENIC STUDY GROUP FOR MDS/JMML/SAA, MEMBER OF THE EWOG-MDS/SAA WORKING GROUP

Author

Petrikkos, Loizos, Servitzoglou, Marina, Dana, Eleni, Pelagiadis, Iordanis, Kelaidi, Charikleia, Antoniadi, Kondilia, Ioannidou, Eleni - Dikaia, Bountali, Aikaterini, Manola, Kalliopi, Stefanaki, Kalliopi, Stiakaki, Eftichia, Kosmidis, Helen, Peristeri, Ioulia, Baka, Margarita, and Polychronopoulou, Sophia

Published
2023
Full Text
View/download PDF

6. P18 - IMMUNOPHENOTYPE IN SAMD9/9L SYNDROME: CORRELATIONS WITH MORPHOLOGY

Author

Kelaidi, Charikleia, Tzanoudaki, Marianna, Petrikkos, Loizos, Dana, Eleni, Tourkantoni, Natalia, Pelagiadis, Iordanis, Antoniadi, Kondylia, Ioannidou, Eleni-Dikaia, Kourti, Maria, Kosmidis, Helen, Stiakaki, Eftychia, Oikonomou, Marina, Goussetis, Evgenios, Peristeri, Ioulia, Kattamis, Antonis, Bountali, Aikaterini, Manola, Kalliopi, Stefanaki, Kalliopi, and Polychronopoulou, Sophia

Published
2023
Full Text
View/download PDF

8. Allogeneic hematopoietic stem cell transplantation in infants is associated with significant morbidity and mortality

Author

Oikonomopoulou, Christina, primary, Paisiou, Anna, additional, Ioannidou, Eleni‐Dikaia, additional, Komitopoulou, Anna, additional, Kaisari, Aikaterini, additional, Zisaki, Kalliopi, additional, Kastamoulas, Michalis, additional, Stavroulaki, Georgia, additional, Giannakopoulou, Aikaterini, additional, Vessalas, George, additional, Kitra‐Roussou, Vassiliki, additional, Goussetis, Evgenios, additional, and Peristeri, Ioulia, additional

Published
2022
Full Text
View/download PDF

9. Is Carbapenem-resistant Klebsiella pneumoniae Infection in Pediatric Bone Marrow Transplantation Recipients Inevitably Fatal?

Author

Komitopoulou, Anna Paisiou, Anna Oikonomopoulou, Christina and Kaisari, Katerina Ioannidou, Eleni D. Tzannou, Ifigeneia and Sipsas, Nikolaos V. Vessalas, George Peristeri, Ioulia and Goussetis, Evgenios Kitra, Vasiliki

Subjects
polycyclic compounds, biochemical phenomena, metabolism, and nutrition, bacterial infections and mycoses
Abstract

Carbapenem resistance, most notably in Klebsiella pneumonia (KPC), results in infections associated with significant morbidity and mortality. Here we report 2 cases of adolescent patients with KPC infection after high-risk bone marrow transplantation, who eventually succumbed from other causes and review the epidemiology and treatment options for KPC infections in this vulnerable population.

Published
2022

10. Acute Gastrointestinal Graft-versus-Host Disease in Pediatric Patients: Serum Albumin on Day 5 from Initiation of Therapy Correlates with Nonrelapse Mortality and Overall Survival

Author

Goussetis, Evgenios, Paisiou, Anna, Kitra, Vasiliki, Peristeri, Ioulia, Vessalas, George, Stefanaki, Kaliopi, Panayotou, Ioanna, Giamaiou, Konstantina, Kontou, Eleftheria, Kitzoni, Margaret, Dimopoulou, Maria N., Karkelis, Savvas, Kafritsa, Yota, Rapsomaniki, Eleni, Papassotiriou, Ioannis, Tsirigotis, Panagiotis, Roma, Eleftheria, and Graphakos, Stelios

Published
2011
Full Text
View/download PDF

13. Diagnostic Capacity for Invasive Fungal Infections in the Greek Paediatric Haematology-Oncology Units: Report from the Infection Working Group of the Hellenic Society of Paediatric Haematology-Oncology

Author

Markantonatou, Anthi-Marina, primary, Tragiannidis, Athanasios, additional, Galani, Vasiliki, additional, Doganis, Dimitrios, additional, Antoniadi, Kondilia, additional, Tsipou, Haroula, additional, Lambrou, Maria, additional, Katzilakis, Nikolaos, additional, Paisiou, Anna, additional, Palabougiouki, Maria, additional, Servitzoglou, Marina, additional, Papakonstantinou, Eugenia, additional, Peristeri, Ioulia, additional, Stiakaki, Efthichia, additional, Kosmidis, Eleni, additional, Polychronopoulou, Sophia, additional, Kattamis, Antonios, additional, and Vyzantiadis, Timoleon-Achilleas, additional

Published
2021
Full Text
View/download PDF

15. Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with β‐thalassaemia

Author

Oikonomopoulou, Christina, primary, Paisiou, Anna, additional, Komitopoulou, Anna, additional, Ioannidou, Eleni‐Dikaia, additional, Kaisari, Aikaterini, additional, Tzannou, Ifigeneia, additional, Mpourazani, Evdoxia, additional, Vessalas, George, additional, Peristeri, Ioulia, additional, Kitra‐Roussou, Vassiliki, additional, and Goussetis, Evgenios, additional

Published
2021
Full Text
View/download PDF

23. Is Carbapenem-resistant Klebsiella pneumoniaeInfection in Pediatric Bone Marrow Transplantation Recipients Inevitably Fatal?

Author

Komitopoulou, Anna, Paisiou, Anna, Oikonomopoulou, Christina, Kaisari, Katerina, Ioannidou, Eleni D., Tzannou, Ifigeneia, Sipsas, Nikolaos V., Vessalas, George, Peristeri, Ioulia, Goussetis, Evgenios, and Kitra, Vasiliki

Abstract

Carbapenem resistance, most notably in Klebsiella pneumonia(KPC), results in infections associated with significant morbidity and mortality. Here we report 2 cases of adolescent patients with KPC infection after high-risk bone marrow transplantation, who eventually succumbed from other causes and review the epidemiology and treatment options for KPC infections in this vulnerable population.

Published
2022
Full Text
View/download PDF

24. Severe aplastic anaemia in children: Impact of histopathology profile and treatment on very long‐term outcomes.

Author

Kelaidi, Charikleia, Makis, Alexandros, Tzotzola, Vasiliki, Antoniadi, Kondylia, Petrikkos, Loizos, Tsitsikas, Konstantinos, Peristeri, Ioulia, Kitra, Vasiliki, Stefanaki, Kalliopi, and Polychronopoulou, Sophia

Subjects
APLASTIC anemia, HISTOPATHOLOGY, CELL transplantation, BONE marrow, B cells
Abstract

Aim: To assess very long‐term outcomes of children with severe aplastic anaemia (SAA) and impact of histopathology and of different treatments over time. Methods: We conducted a retrospective study of 57 consecutive patients with SAA during 1973‐2019. According to period, treatment consisted of androgens, immunosuppressive treatment (IST) and haematopoietic cell transplantation (HCT) in 14, 31 and 13 patients, respectively. Histopathology immune profiles were studied on bone marrow (BM). Results: Response rate (RR) to androgens was 35%, with long‐term survivorship in 4 of 5 responders. RR and 10‐year overall survival (OS) after IST was 65% and 80%, respectively. RR was higher in girls (92% vs 43% in boys, P =.02). Mean baseline BM values of CD34 + and of B‐lymphocytes in responders vs non‐responders were 1.3% vs 0 (P =.08) and 14.1% vs 9.7% (P =.07), respectively. After IST, BM cellularity gradually increased and cytotoxic T‐lymphocytes decreased (time variation P =.003 and 0.07, respectively). Outcome did not differ between patients with IST or frontline HCT. Ten‐year OS improved over time, increasing from 35.3% to 77.1% and 77% during 1973‐1985, 1986‐2003 and 2004‐2019, respectively. Conclusion: Histopathology may refine response prediction to IST. The course of SAA in children, a previously fatal disease, was altered in recent times. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

25. Successful long-term hematological and immunological reconstitution by autologous cord blood transplantation combined with post-transplant immunosuppression in two children with severe aplastic anemia

Author

Goussetis Evgenios, Avgerinou Georgia, Ioannidou Elda, Filippidou Maria, Oikonomopoulou Christina, Peristeri Ioulia, Vessalas George, Kattamis Antonios, Komitopoulou Anna, Kitra Vasiliki, Paisiou Anna, Kaisari Aikaterini, and Tourkantoni Natalia

Subjects
Transplantation, medicine.medical_specialty, Cord, Cyclophosphamide, business.industry, medicine.medical_treatment, 030232 urology & nephrology, Immunosuppression, 030230 surgery, Severe Aplastic Anemia, Surgery, 03 medical and health sciences, 0302 clinical medicine, Refractory, Cord blood, Pediatrics, Perinatology and Child Health, medicine, business, Cord blood transplantation, medicine.drug
Abstract

aUCBT is a valuable curative option in pediatric patients with refractory idiopathic SAA and no available matched sibling or unrelated donors. Experience in the use of autologous cord blood units in patients with SAA is limited and private for-profit cord blood-banking programs are controversial. We report the successful treatment of two patients with SAA, aged 15 and 24 months, with autologous cord blood combined with immunosuppression. After conditioning with 200 mg/kg cyclophosphamide and ATG, 7.5 mg/kg, 32.2 × 107 /kg, and 3.8 × 107 /kg autologous cord blood nucleated cells were infused, respectively. One of our patients underwent transplantation after failure of IST. Both patients received post-transplant immunosuppression with cyclosporine for 12 months. They remain disease-free 6 years post-transplantation.

Published
2018

26. Toxoplasma gondii: How fatal is it in pediatric allogeneic bone marrow transplantation setting?

Author

Komitopoulou, Anna, Goussetis, Evgenios, Oikonomopoulou, Christina, Paisiou, Anna, Kaisari, Katerina, Ioannidou, Eleni, Sipsas, Nikolaos V., Kosmidis, Helen, Vessalas, Georgios, Peristeri, Ioulia, and Kitra, Vassiliki

Subjects
BONE marrow transplantation, TOXOPLASMA gondii, TOXOPLASMOSIS, TOXOPLASMA
Abstract

Toxoplasmosis is a disease of the immunocompetent population. However, cases of toxoplasma infection associated with immunosuppression have been reported, especially the first months after transplantation. Limited data are available about toxoplasma infection, occurring even many months post‐transplant in pediatric patients with nonmalignant and malignant diseases. We report the cases of three patients with early and late disseminated toxoplasmosis and review the literature. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

29. HLA-Identical Embryos Selected after in Vitro Fertilization and Pre-Implantation Genetic Diagnosis Combined with HLA Typing: A Promising Option for Successful Allogeneic Hematopoietic Stem Cell Transplantation for Children with Genetic or Malignant Disorders Who Lack an HLA-Matched Related or Unrelated Donor

Author

Goussetis, Eugene, primary, Tsirigotis, Panagiotis, additional, Peristeri, Ioulia, additional, Kitra, Vassiliki, additional, Avgerinou, Georgia, additional, Vessalas, George, additional, Paisiou, Anna, additional, Zisaki, Kalliopi, additional, Papassotiriou, Ioannis, additional, Kanavakis, Emmanuel, additional, and Graphakos, Stelios, additional

Published
2014
Full Text
View/download PDF

30. Successful Hematopoietic Stem Cell Transplantation in 2 Children with X-Linked Chronic Granulomatous Disease from Their Unaffected HLA-Identical Siblings Selected Using Preimplantation Genetic Diagnosis Combined with HLA Typing

Author

Goussetis, Evgenios, Konialis, Christopher P., Peristeri, Ioulia, Kitra, Vasiliki, Dimopoulou, Maria, Petropoulou, Theoni, Vessalas, George, Papassavas, Andreas, Tzanoudaki, Marianna, Kokkali, Georgia, Petrakou, Eftychia, Spiropoulos, Antonia, Pangalos, Constantinos G., Pantos, Konstantinos, and Graphakos, Stelios

Published
2010
Full Text
View/download PDF

32. Allogeneic Hematopoietic Stem Cell Transplantation Using An Intravenous Busulfan Based Myeloablative Conditioning without Total Body Irradiation for Pediatric Patients with Acute Lymphoblastic Leukemia

Author

Goussetis, Eugene, primary, Paisiou, Anna, additional, Peristeri, Ioulia, additional, Kitra, Vassiliki, additional, Vessalas, George, additional, Dimopoulou, Maria N, additional, Baltathakis, Ioannis, additional, and Graphakos, Stelios, additional

Published
2010
Full Text
View/download PDF

33. Cytogenetic Diagnostics and Outcome in a Series of Thirty Three Greek Pediatric Acute Myeloid Leukemia Patients

Author

Manola, Kalliopi N, primary, Parcharidou, Agapi, primary, Papadakis, Vassilios, primary, Kalntremtziou, Maria, primary, Stavropoulou, Chryssa, primary, Georgakakos, Vasileios, primary, Paisiou, Anna, primary, Peristeri, Ioulia, primary, Pantelias, Gabriel, primary, Sambani, Constantina, primary, and Polychronopoulou, Sophia, primary

Published
2008
Full Text
View/download PDF

35. Intracoronary Infusion of CD133 + and CD133 − CD34 + Selected Autologous Bone Marrow Progenitor Cells in Patients with Chronic Ischemic Cardiomyopathy: Cell Isolation, Adherence to the Infarcted Area, and Body Distribution

Author

Goussetis, Evgenios, primary, Manginas, Athanassios, additional, Koutelou, Maria, additional, Peristeri, Ioulia, additional, Theodosaki, Maria, additional, Kollaros, Nikolaos, additional, Leontiadis, Evangelos, additional, Theodorakos, Athanasios, additional, Paterakis, George, additional, Karatasakis, George, additional, Cokkinos, Dennis V., additional, and Graphakos, Stelios, additional

Published
2006
Full Text
View/download PDF

37. Intracoronary Infusion of CD133+ and CD133-CD34+ Selected Autologous Bone Marrow Progenitor Cells in Patients with Chronic Ischemic Cardiomyopathy: Cell Isolation, Adherence to the Infarcted Area, and Body Distribution.

Author

Goussetis, Evgenios, Manginas, Athanassios, Koutelou, Maria, Peristeri, Ioulia, Theodosaki, Maria, Kollaros, Nikolaos, Leontiadis, Evangelos, Theodorakos, Athanasios, Paterakis, George, Cokkinos, Dennis V., and Graphakos, Stelios

Subjects
CARDIOMYOPATHIES, BONE marrow, ISCHEMIA, BLOOD circulation disorders, BLOOD vessels, BILIARY tract, LYMPHOID tissue, STEM cell research
Abstract

Central issues in intracoronary infusion (ICI) of bone marrow (BM)-cells to damaged myocardium for improving cardiac function are the cell number that is feasible and safe to be administrated as well as the retention of cells in the target area. Our study addressed these issues in eight patients with chronic ischemic cardiomyopathy undergoing ICI of selected BM-progenitors. We could immunomagnetically isolate 0.8 ± 0.32 × 107 CD133+ cells and 0.75 ± 0.24 × 107 CD133-CD34+ cells from 310 ± 40 ml BM. After labeling these cells with 99mTc-hexamethylpropylenamineoxime, they were infused into the infarct-related artery without any complication. Scintigraphic images 1 (eight patients) and 24 hours (four patients) after ICI revealed an uptake of 9.2% ± 3.6 and 6.8% ± 2.4 of the total infused radioactivity in the infarcted area of the heart, respectively; the remaining activity was distributed mainly to liver and spleen. We conclude that through ICI of CD133+ and CD133-CD34+ BM-progenitors a significant number of them are preferentially attracted to and retained in the chronic ischemic myocardium. [ABSTRACT FROM AUTHOR]

Published
2006
Full Text
View/download PDF

40. Successful long-term hematological and immunological reconstitution by autologous cord blood transplantation combined with post-transplant immunosuppression in two children with severe aplastic anemia.

Author

Avgerinou G, Oikonomopoulou C, Kaisari A, Ioannidou E, Komitopoulou A, Paisou A, Tourkantoni N, Filippidou M, Kattamis A, Vessalas G, Peristeri I, Goussetis E, and Kitra V

Subjects
Anemia, Aplastic blood, Anemia, Aplastic immunology, Child, Preschool, Combined Modality Therapy, Humans, Infant, Male, Transplantation, Autologous, Anemia, Aplastic therapy, Cord Blood Stem Cell Transplantation methods, Cyclosporine therapeutic use, Immunosuppressive Agents therapeutic use
Abstract

aUCBT is a valuable curative option in pediatric patients with refractory idiopathic SAA and no available matched sibling or unrelated donors. Experience in the use of autologous cord blood units in patients with SAA is limited and private for-profit cord blood-banking programs are controversial. We report the successful treatment of two patients with SAA, aged 15 and 24 months, with autologous cord blood combined with immunosuppression. After conditioning with 200 mg/kg cyclophosphamide and ATG, 7.5 mg/kg, 32.2 × 10 7 /kg, and 3.8 × 10 7 /kg autologous cord blood nucleated cells were infused, respectively. One of our patients underwent transplantation after failure of IST. Both patients received post-transplant immunosuppression with cyclosporine for 12 months. They remain disease-free 6 years post-transplantation., (© 2018 Wiley Periodicals, Inc.)

Published
2019
Full Text
View/download PDF

41. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.

Author

Goussetis E, Manginas A, Koutelou M, Peristeri I, Theodosaki M, Kollaros N, Leontiadis E, Theodorakos A, Paterakis G, Karatasakis G, Cokkinos DV, and Graphakos S

Subjects
AC133 Antigen, Adult, Bone Marrow Cells immunology, Bone Marrow Transplantation methods, Chronic Disease, Flow Cytometry, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Ischemia pathology, Myocardium immunology, Myocardium pathology, Stem Cells immunology, Transplantation, Autologous, Antigens, CD immunology, Antigens, CD34 immunology, Bone Marrow Cells cytology, Glycoproteins immunology, Myocardial Ischemia surgery, Peptides immunology, Stem Cells cytology
Abstract

Central issues in intracoronary infusion (ICI) of bone marrow (BM)-cells to damaged myocardium for improving cardiac function are the cell number that is feasible and safe to be administrated as well as the retention of cells in the target area. Our study addressed these issues in eight patients with chronic ischemic cardiomyopathy undergoing ICI of selected BM-progenitors. We could immunomagnetically isolate 0.8 +/- 0.32 x 10(7) CD133(+) cells and 0.75 +/- 0.24 x 10(7) CD133(-)CD34(+) cells from 310 +/- 40 ml BM. After labeling these cells with (99m)Tc-hexamethylpropylenamineoxime, they were infused into the infarct-related artery without any complication. Scintigraphic images 1 (eight patients) and 24 hours (four patients) after ICI revealed an uptake of 9.2% +/- 3.6 and 6.8% +/- 2.4 of the total infused radioactivity in the infarcted area of the heart, respectively; the remaining activity was distributed mainly to liver and spleen. We conclude that through ICI of CD133(+) and CD133(-)CD34(+) BM-progenitors a significant number of them are preferentially attracted to and retained in the chronic ischemic myocardium.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results